Syphilis OTC Test Developer NOWDiagnostics Raises $22.5M

 
• By Ryan Nelson
  
NOWDx entered a de novo classification request to the US FDA for its Syphilis OTC test in January. • Source: Shutterstock
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from United States

More from North America